Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Current Deferred Revenue (2020 - 2026)

Cytosorbents filings provide 8 years of Current Deferred Revenue readings, the most recent being $182000.0 for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 69.46% to $182000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $182000.0, a 69.46% decrease, with the full-year FY2025 number at $182000.0, down 69.46% from a year prior.
  • Current Deferred Revenue hit $182000.0 in Q4 2025 for Cytosorbents, down from $403000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.9 million in Q4 2021 to a low of $182000.0 in Q4 2025.
  • Median Current Deferred Revenue over the past 5 years was $571014.0 (2024), compared with a mean of $866621.8.
  • Biggest five-year swings in Current Deferred Revenue: soared 167.36% in 2021 and later plummeted 69.46% in 2025.
  • Cytosorbents' Current Deferred Revenue stood at $1.9 million in 2021, then decreased by 22.11% to $1.5 million in 2022, then fell by 8.96% to $1.4 million in 2023, then plummeted by 56.84% to $596000.0 in 2024, then plummeted by 69.46% to $182000.0 in 2025.
  • The last three reported values for Current Deferred Revenue were $182000.0 (Q4 2025), $403000.0 (Q3 2025), and $361000.0 (Q2 2025) per Business Quant data.